URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) ) or thrombin. The blood of male donor patients (n = 60) with
acute de novo thrombosis (n = 90) was used. Using
Gareev, I.,
Gallyametdinov, A.,
Beylerli, O.,
Valitov, E.,
Alyshov, A.,
Pavlov, V.,
Izmailov, A.,
Zhao, S. (2021) was identified - severe
acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), and the disease itself
factors, which included the severity of COVID-19,
acute coronary syndrome, multiple organ failure
, or
acutely in Experiment 2. In Experiment 2, ketanserin enhanced the effect of N-199/1, decreasing ID by 36